Skip to main content
SpringerLink
Log in

Acute effects of intravenous nisoldipine on left ventricular function after acute myocardial infarction

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

Nisoldipine is a calcium antagonist with potent coronary vasodilating effects in patients with chronic stable angina pectoris. In an initial study we showed that intravenous nisoldipine, given 24–72 hours after uncomplicated myocardial infarction, was a safe and feasible intervention that had beneficial effects on global and regional myocardial function. We subsequently studied the acute effects of nisoldipine in six patients within 24 hours (mean 14±4 hours) after the onset of myocardial infarction. Nisoldipine was administered as a 4.5 µg/kg intravenous bolus over 3 minutes, followed by intravenous infusion of 0.2 µg/kg over 60 minutes. Radionuclide angiography, cardiac output, and intraarterial blood pressure measurements were performed before and during nisoldipine. Left ventricular ejection fraction increased from 48.3±10.3% to 55.3±11.8% (p=0.034) during nisoldipine infusion. Regional wall motion score changed during nisoldipine infusion from 3.3±2.5 to 1.8±2.6 (p=0.027). Cardiac output increased from 5.5±1.0 to 7.3±1.3 1/min (p=0.0001). I eart rate increased from 78±12 to 88±11 min−1 (p=0.004). Mean arterial blood pressure decreased from 92±20 to 79±13 mmI g (p=0.038). The rate-pressure product did not change significantly during nisoldipine infusion. It is concluded that nisoldipine improves global and regional left ventricular function in patients with acute myocardial infarction within the first 24 hours.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kazda S, Garthoff B, Meyer H, et al. Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1.4-dihydro-2.6 dimethyl-4-(2-nitrophenyl)-3.5-pyridinecarboxylate (nisoldipine, BAY K 5552).Drug Res 1980;30:2144–2162.

    Google Scholar 

  2. Warltier DC, Meils CM, Gross GJ, Brooks HL. Blood flow in normal and acutely ischemic myocardium after verapamil, diltiazem, and nisoldipine (BAY K 5552), a new dihydropyridine calcium antagonist.J Pharmacol Exp Ther 1981;218:296–301.

    Google Scholar 

  3. Maxwell GM, Crompton S, Renics V. Effect of nisoldipine upon the general and coronary hemodynamics of the anaesthetized dog.J Cardiovasc Pharmacol 1982;4:393–399.

    Google Scholar 

  4. Warltier D, Zyvoloski M, Gross GJ, Brooks HL. Comparative actions of dihydropyridine slow channel blocking agents in conscious dogs: Systemic and coronary hemodynamics with and without combined beta-adrenergic blockade.J Pharmacol Exp Ther 1984;230:367–375.

    Google Scholar 

  5. Jost S, Rafflenbeul W, Mogwitz U, et al. Coronary vasodilation with dihydropyridines—a pharmacokinetic study.Eur Heart J 1989;10(Suppl F):147–152.

    Google Scholar 

  6. Lathrop DA, Valle-Aguilera JR, Milard RW, et al. Comparative electrophysiologic and coronary hemodynamic effects of diltiazem, nisoldipine and verapamil on myocardial tissue.Am J Cardiol 1982;49:613–620.

    Google Scholar 

  7. Klein HH, Nordbeck H, Kreuzer H. Effect of the calcium antagonist nisoldipine on electrophysiologic parameters in the human.Z Kardiol 1983;72:180–182.

    Google Scholar 

  8. Serruys PW, Suryapranata H, Planellas J, et al. Acute effects of intravenous nisoldipine on left ventricular function and coronary hemodynamics.Am J Cardiol 1985;56:140–146.

    Google Scholar 

  9. Soward AL, de Feyter PJ, Hugenholtz PG, Serruys PW. Coronary and systemic hemodynamic effects of intravenous nisoldipine.Am J Cardiol 1986;58:1199–1203.

    Google Scholar 

  10. Soward AL, de Feyter PJ, Hugenholtz PG, Serruys PW. Maintenance of increased coronary blood flow in excess of demand by nisoldipine administered as an intravenous infusion.Am J Cardiol 1986;58:1204–1208.

    Google Scholar 

  11. Kimball BP, Watson KD, Bui S, Frankel D, et al. Preservation of left ventricular performance with ischemic dysfunction by intravenous nisoldipine.Am J Cardiol 1990;66:400–405.

    Google Scholar 

  12. Nienaber CA, Spielmann RP, Aschenberg W, Fehr A, Clausen A, Bleifeld W. Comparison of the acute hemodynamic response to intravenous nisoldipine (BAY K 5552) and intravenous nifedipine for left ventricular dysfunction secondary to myocardial infarction.Am J Cardiol 1987;60:836–841.

    Google Scholar 

  13. Kimchi A, Ellrodt G, Charuzi Y, Shell W, Murata GH. Salutary hemodynamic and sustained clinical benefits of nisoldipine, a new calcium channel blocker, in patients with recurrent ischemia and severe heart failure.Am Heart J 1985;110:496–498.

    Google Scholar 

  14. Haitas B, Meyer TE, Angel ME, Reef E. Comparative haemodynamic effects of intravenous nisoldipine and hydralazine in congestive heart failure.Br J Pharmacol 1990;29:366–368.

    Google Scholar 

  15. Lewis BS, Shefer A, Merdler A, et al. Effect of the second-generation calcium channel blocking drug nisoldipine on diastolic left ventricular function in heart failure.Am Heart J 1989;118:505–511.

    Google Scholar 

  16. Silke B, Frais MA, Muller P, Verma SP, Reynolds G, Taylor SH. Hemodynamic dose-response effects of intravenous nisoldipine in coronary artery disease.Br J Clin Pharmacol 1985;20:675–680.

    Google Scholar 

  17. Tumas J, Deth R, Kloner RA. Effects of nisoldipine, a new calcium antagonist, on myocardial infarct size and cardiac dynamics following acute myocardial infarction.J Cardiovasc Pharmacol 1985;7:361–367.

    Google Scholar 

  18. Herbaczynska-Cedro K, Gordon-Majszak W. Nisoldipine inhibits lipid peroxidation induced by coronary occlusion in pig myocardium.Cardiovasc Res 1990;24:683–687.

    Google Scholar 

  19. Fagbemi O, Parratt JR. Suppression by orally-administered nifedipine, nisoldipine, and niludipine of early, life-threatening ventricular arrhythmias resulting from acute myocardial ischemia.Br J Pharmacol 1981;74:12–14.

    Google Scholar 

  20. De Nooyer RC, van der Wall EE, Manger Cats V, et al. The acute effects of intravenous nisoldipine on left ventricular function 24 to 72 hours after uncomplicated acute myocardial infarction.Cardiovasc Drugs Ther 1988;2:673–678.

    Google Scholar 

  21. Van der Wall EE, Chin JC, Manger Cats V, et al. Myocardial stunning after prolonged ischaemia: Effects of calcium antagonists. In: Buller N, Henderson AH, Krayenbühl HP, eds.Left Ventricular Function in Stunned and Hibernating Myocardium. Amsterdam: Excerpta Medica, 1991:77–89.

    Google Scholar 

  22. Reiber JCH, Lie SP, Simoons ML, et al. Clinical validation of fully automated computation of ejection fraction from gated equilibrium blood-pool scintigrams.J Nucl Med 1983;24:1099–1105.

    Google Scholar 

  23. Van der Wall EE, Kernkamp HJ, Simoons ML, et al. Influence of nifedipine on left ventricular perfusion and function in patients with unstable angina: Evaluation with radionuclide techniques.Eur J Nucl Med 1986;11:428–433.

    Google Scholar 

  24. Dash H, Copenhaver GL, Ensminger S. Improvement in regional wall motion and left ventricular relaxation after administration of diltiazem in patients with coronary artery disease.Circulation 1985;72:353–363.

    Google Scholar 

  25. Vigorito C, Giordano A, De Caprio L, et al. Regional coronary hemodynamic effects of diltiazem in man.Am Heart J 1988;116:799–805.

    Google Scholar 

  26. Nayler WG. Calcium antagonists and the stunned heart. In: Nayler WG, ed.Second Generation of Calcium Antagonists. Berlin: Springer Verlag, 1991:97–116.

    Google Scholar 

  27. Du Toit EF, Opie LH. Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion.Circ Res 1992;70:960–967.

    Google Scholar 

  28. Previtali M, De Ponti R, Storti C, Panciroli C, Salerno JA. Hemodynamic effects of nisoldipine in acute myocardial infarction. In: Lichtlen PR, Hugenholtz PG, eds.Nisoldipine. Stuttgart: Schattauer, 1988:142–152.

    Google Scholar 

  29. Wilson J, Commerford PJ, Millar RS, Opie LH. Hemodynamic effects of nisoldipine, a highly specific calcium antagonist, in patients with acute myocardial infarction.Cardiovasc Drugs Ther 1992;6:41–46.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, University Hospital Leiden, Rijnsburgerweg 10, 2333, AA Leiden, The Netherlands

    Ernst E. van der Wall, Volkert Manager Cats, Jan C. Chin & Albert V. G. Bruschke

  2. Department of Nuclear Medicine, University Hospital, Leidin, The Netherlands

    Ernest J. K. Pauwels

Authors
  1. Ernst E. van der Wall
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Volkert Manager Cats
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jan C. Chin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ernest J. K. Pauwels
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Albert V. G. Bruschke
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

van der Wall, E.E., Manager Cats, V., Chin, J.C. et al. Acute effects of intravenous nisoldipine on left ventricular function after acute myocardial infarction. Cardiovasc Drug Ther 8 (Suppl 2), 345–351 (1994). https://doi.org/10.1007/BF00877319

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00877319

Key words

Search

Navigation